USANA Health Sciences, Inc. Common Stock (USNA)

Health and wellness products company USANA Health Sciences (NYSE:USNA) announced better-than-expected revenue in Q2 CY2025, with sales up 10.8% year on year to $235.8 million. The company’s full-year revenue guidance of $960 million at the midpoint came in 1.4% above analysts’ estimates. Its non-GAAP profit of $0.74 per share was 37% above analysts’ consensus estimates.

Shares of health and wellness products company USANA Health Sciences (NYSE:USNA) jumped 12.4% in the afternoon session after reporting strong second-quarter financial results that surpassed analyst expectations and reaffirming its full-year outlook. 

As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the consumer staples industry, including WD-40 (NASDAQ:WDFC) and its peers.

Health and wellness products company USANA Health Sciences (NYSE:USNA) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 10.9% year on year to $236 million. The company’s full-year revenue guidance of $960 million at the midpoint came in 1.4% above analysts’ estimates. Its non-GAAP profit of $0.74 per share was 37% above analysts’ consensus estimates.

Health and wellness products company USANA Health Sciences (NYSE:USNA) will be announcing earnings results this Tuesday after market close. Here’s what investors should know.

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.

Regarded as defensive investments, consumer staples stocks are generally safe bets in choppy markets. Unfortunately, the sector hasn’t provided much protection lately as it pulled back by 10.6% over the past six months. This drop was particularly disheartening since the S&P 500 held its ground.

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the personal care stocks, including USANA (NYSE:USNA) and its peers.

Health and wellness products company USANA Health Sciences (NYSE:USNA) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 9.5% year on year to $249.5 million. The company’s full-year revenue guidance of $960 million at the midpoint came in 2% above analysts’ estimates. Its non-GAAP profit of $0.73 per share was 4.3% above analysts’ consensus estimates.

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.

Health and wellness products company Herbalife (NYSE:HLF) will be announcing earnings results tomorrow afternoon. Here’s what to expect.

Wellness company Medifast (NYSE:MED) will be reporting results tomorrow after market hours. Here’s what to expect.

Health and wellness products company USANA Health Sciences (NYSE:USNA) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 9.7% year on year to $250 million. The company’s full-year revenue guidance of $960 million at the midpoint came in 2% above analysts’ estimates. Its non-GAAP profit of $0.73 per share was 4.3% above analysts’ consensus estimates.

Health and wellness products company USANA Health Sciences (NYSE:USNA) will be announcing earnings results tomorrow afternoon. Here’s what to expect.

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how personal care stocks fared in Q4, starting with Edgewell Personal Care (NYSE:EPC).

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Estée Lauder (NYSE:EL) and its peers.

The Russell 2000 is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.

Consumer staples stocks are solid insurance policies in frothy markets ripe for corrections. Unfortunately, the sector hasn’t provided much protection lately as it pulled back by 10% over the past six months. This drop was worse than the S&P 500’s 1.6% fall.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at personal care stocks, starting with USANA (NYSE:USNA).